Estimates Revisions Beam Therapeutics Inc.
Stocks
BEAM
US07373V1052
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 18/08/2026 BST
|
After hours 23:10:26 | |||
| 26.57 USD | -1.96% |
|
26.89 | +1.20% |
| 08-05 | BofA Adjusts Price Target on Beam Therapeutics to $43 From $47 | MT |
| 08-04 | Beam Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- BEAM Stock
- Consensus Beam Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
